News

Development of the world’s leading potential coeliac disease vaccine, Nexvax2®, has progressed, with the company ImmusanT Inc. initiating a Phase 2 study in people with coeliac disease living in Australia and New Zealand. The study aims to further assess safety,…

The Allergen Bureau is delighted to welcome Mondelēz International as a new Allergen Bureau Full Member organisation. Mondelēz International is a previous Full Member and we are grateful for their renewed commitment to this important food industry initiative. Mondelēz International…

 Elsevier, and the editors of the official journals of the American Academy of Allergy, Asthma & Immunology (AAAAI), have made several recent food allergy research articles free to access until 30 November 2018. The Journal of Allergy and Clinical Immunology,…

UK-based international sandwich shop, Pret a Manger, is in the spotlight following the allergy-related deaths of two customers in recent years. With over 500 shops in nine countries selling 218 million products a year, perhaps more was expected of the…

At a recent update on national progress in the management of allergies, Associate Professor Richard Loh, Co-Chair of the National Allergy Strategy Steering Committee and paediatric clinical immunology/allergy specialist, encouraged the Australian Government to maintain their commitment to addressing the…

There are calls for more stringent labelling measures after a study of consumer group Allergy & Anaphylaxis Australia members showed many have suffered anaphylactic reactions after eating foods that were not labelled for the suspected allergen. During a nine month…